CLINICAL_TRIALS
ClinicalTrials.gov record update
Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02875548
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:29:00.240976+00:00
- Published At
- 2025-11-04T00:00:00+00:00
- Record Updated At
- 2025-11-04
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Diffuse Large B-cell Lymphoma (DLBCL)", "Follicular Lymphoma (FL)", "Synovial Sarcoma", "Epitheliod Sarcoma (ES)", "Mesothelioma", "Advanced Solid Tumors", "Renal Medullary Carcinoma", "Non-Hodgkin Lymphoma (NHL)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-04"- protocolSection.identificationModule.nctId
"NCT02875548"- protocolSection.identificationModule.officialTitle
"Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.